Clinical Trials Arena January 17, 2025
The Clinical Trials Arena spoke to industry experts about what the sector can expect in 2025.
It has been a turbulent time for the pharmaceutical industry – especially in regard to the clinical trial sector. From reduced investment, to a lack of public trust in the industry, it has been difficult, especially for small and medium-sized biotech’s, to get efficient clinical trials off the ground.
On top of these challenges, the industry has also seen a change in demand, with the types of therapies in the pipeline, such as cell and gene therapies, requiring a shift away from the gold standard randomised controlled trial (RCT) model. As a result, companies have had to learn how to effectively run adaptive trial...
Today's Sponsors
Today's Sponsor